Evidence map›Paper›PMID 32302544›Full record

ArticleDevelopmental cell2020

Non-Canonical Caspase Activity Antagonizes p38 MAPK Stress-Priming Function to Support Development.

Benjamin P Weaver, Yi M Weaver, Shizue Omi, Wang Yuan, Jonathan J Ewbank, Min Han

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. AScience signaling · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. UPReLife · 2024
    Article
  11. Cutting through stress.Nature metabolism · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. UBR5 is a novel regulator of WNK1 stability.American journal of physiology. Cell physiology · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Benjamin P WeaverDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder and Howard Hughes Medical Institute, Boulder, CO 80309, USA. Electronic address: benjamin.weaver@utsouthwestern.edu.
Yi M WeaverDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder and Howard Hughes Medical Institute, Boulder, CO 80309, USA.
Shizue OmiAix Marseille University, CNRS, INSERM, CIML, Turing Centre for Living Systems, Marseille, France.
Wang YuanDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Jonathan J EwbankAix Marseille University, CNRS, INSERM, CIML, Turing Centre for Living Systems, Marseille, France.
Min HanDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder and Howard Hughes Medical Institute, Boulder, CO 80309, USA.
The University of Texas Southwestern Medical Center · USAix-Marseille Université · FRCentre National de la Recherche Scientifique · FRUniversity of Colorado Boulder · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
RAS MEDIATED SIGNAL TRANSDUCTION IN C. ELEGANSR01GM047869 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI HAN, MIN · 1992 to 2020
$5.0M
Proteolytic Mechanisms Mediating Diverse Non-Apoptotic Caspase FunctionsR35GM133755 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Benjamin P. Weaver · 2019 to 2026
$3.7M
Novel Nutrient Functions and Sensing MechanismsR35GM139631 · NIGMS · UNIVERSITY OF COLORADO · PI MIN HAN · 2021 to 2026
$2.6M
Mechanism by which fatty acid metabolism impacts muscle maintenanceR01AR074503 · NIAMS · UNIVERSITY OF COLORADO · PI HAN, MIN · 2019 to 2023
$1.7M
Howard Hughes Medical InstituteNIAMS NIH HHS R01 AR074503NIGMS NIH HHS R01 GM047869NIGMS NIH HHS R35 GM133755NIGMS NIH HHS R35 GM139631NIH HHS P40 OD010440
6 · The paper itself

Abstract

Recent studies have revealed non-canonical activities of apoptotic caspases involving specific modulation of gene expression, such as limiting asymmetric divisions of stem-like cell types. Here we report that CED-3 caspase negatively regulates an epidermal p38 stress-responsive MAPK pathway to promote larval development in C. elegans. We show that PMK-1 (p38 MAPK) primes animals for encounters with hostile environments at the expense of retarding post-embryonic development. CED-3 counters this function by directly cleaving PMK-1 to promote development. Moreover, we found that CED-3 and PMK-1 oppose each other to balance developmental and stress-responsive gene expression programs. Specifically, expression of more than 300 genes is inversely regulated by CED-3 and PMK-1. Analyses of these genes showed enrichment for epidermal stress-responsive factors, including the fatty acid synthase FASN-1, anti-microbial peptides, and genes involved in lethargus states. Our findings demonstrate a non-canonical role for a caspase in promoting development by limiting epidermal stress response programs.

Indexed as

Stress, PhysiologicalAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCaspasesGene Expression RegulationMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesProteolysisCaenorhabditis elegans ProteinsCaspasesced-3 protein, C elegansMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPmk-1 protein, C elegansDUSPinnate immunitykinasemetabolismNLP-29non-apoptoticphosphataseproteostasistranslationVHP-1

Identifiers

PMID32302544
PMCPMC7641037
OpenAlexW3016506833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.